Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
Researcher (R1) Country Singapore Application Deadline 26 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
Singapore Application Deadline 30 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
Singapore Application Deadline 26 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
for renewal. The group is committed to discovering and developing new radiopharmaceuticals for cancer theranostics (therapeutics and diagnostics) that are clinically translatable. The team puts special emphasis
-
Researcher (R1) Country Singapore Application Deadline 26 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
Researcher (R1) Country Singapore Application Deadline 27 Oct 2026 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
for online education, team collaboration, and workplace training with a focus on real-time interactive simulation. (app developer) Design, build, and implement a multiplayer architecture and backend services
-
Deadline 30 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position
-
Centre for Advanced Research and Education in Singapore (CARES) that aims to develop neuroscience-based interventions for lifelong flexible learning. Launched in October 2020 and funded by the National
-
programmes, is named after local philanthropist Tan Sri Dato Lee Kong Chian. Established in 2010 by Nanyang Technological University, Singapore, in partnership with Imperial College London, LKCMedicine aims